Measurement of drug exposure and its clearance from the biological system is one of the most critical phases of drug development process. With the team’s rich experience in conducting safety assessments, BRC offers fast, reliable and a diverse range of in vivo GLP compliant pharmacokinetic screening services in multiple animal models.
Our pharmacokineticists will work as an extension of your team and support you expedite the development goals by providing insights on study designs and interpretations for pharmacokinetics data as they are vital in selection of species, dosing regimen, design of preclinical toxicology screening and formulation development.
Our unique approach in understanding the physiochemical properties of the test compound will give us an advantage to anticipate the challenges and develop mitigation strategies during sample collection and processing. This combined with our rich experience in bioanalysis can generate reliable pharmacokinetic data for stratification of promising compounds or products for further development.
The scientific team at BRC are well versed with variety of data analysis platforms and modelling tools critical in providing meaningful data sets to our clients for better decision making in advancing potential therapeutic compounds or products for further development.
We offer regular and customized services to fulfil the research needs of our clients
We have the expertise in guiding you choose the appropriate animal model for your development program and conduct the screening of your therapeutic compound.
We ensure thorough training and competence of our personnel for blood sample collection to minimize the stress and maintain the health and welfare of the animal.
Our scientific team has the expertise in selection of specific route and are competent enough to administer the test compound via multiple routes that can potentially contribute to experimental refinement and minimize adverse effects on animals
